This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International
September 23-26, 2024
Hynes Convention CenterBoston, USA

Amir Hefni, PhD MBA.
CEO at Resolution Therapeutics


Amir is the CEO of Resolution Therapeutics. Prior to joining Resolution, he was the Global Head of Cell and Gene Therapy at Novartis where he was responsible for the company’s global product development, manufacturing, supply chain and commercialisation of innovative cell therapies. Previously, he was a Global Asset Lead in Oncology at Ipsen and was Executive Director US Oncology at Bristol-Myers Squibb. Amir holds a BSc and PhD in Pharmacology from King’s College London and an MBA from Warwick Business School.

Agenda Sessions

  • Pioneering Macrophage Cell Therapy in End Stage Liver Disease